Pimblett Emily 4
4 · Eliem Therapeutics, Inc. · Filed Jun 21, 2024
Insider Transaction Report
Form 4
Pimblett Emily
SVP, Finance & CAO
Transactions
- Sale
Common Stock
2024-06-20$7.21/sh−1,245$8,982→ 3,755 total - Exercise/Conversion
Restricted Stock Units
2024-06-18−5,000→ 35,000 total→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2024-06-18+5,000→ 5,000 total
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
- [F3]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F4]The shares subject to this RSU shall vest at a rate of 1/8th of the total number of shares on the three-month anniversary of March 18, 2024 (the "March 2024 Vesting Commencement Date") and 1/8th of the total number of shares each three-month anniversary of the March 2024 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the two-year anniversary of the March 2024 Vesting Commencement Date.